Activation of CD8+ T cells is crucial for the prevention of tumorigenesis and the induction of tumor regression and correlates with the long survival of patients with pancreatic cancer (Zhang et al., 2020). This evidence concerns the gene CD8A and familial pancreatic carcinoma.